Literature DB >> 29194083

Management of Reducible Ventral Hernias: Clinical Outcomes and Cost-effectiveness of Repair at Diagnosis Versus Watchful Waiting.

Lindsey L Wolf1,2,3, Julius I Ejiofor1,2,3, Ye Wang1, Myriam G Hunink4,5, Elena Losina6, Adil H Haider1,2, Douglas S Smink1,3.   

Abstract

OBJECTIVE: To compare long-term clinical and economic outcomes associated with 3 management strategies for reducible ventral hernia: repair at diagnosis (open or laparoscopic) and watchful waiting.
BACKGROUND: There is variability in ventral hernia management. Recent data suggest watchful waiting is safe; however, long-term clinical and economic outcomes for different management strategies remain unknown.
METHODS: We built a state-transition microsimulation model to forecast outcomes for individuals with reducible ventral hernia, simulating a cohort of 1 million individuals for each strategy. We derived cohort characteristics (mean age 58 years, 63% female), hospital costs, and perioperative mortality from the Nationwide Inpatient Sample (2003-2011), and additional probabilities, costs, and utilities from the literature. Outcomes included prevalence of any repair, emergent repair, and recurrence; lifetime costs; quality-adjusted life years (QALYs); and incremental cost-effectiveness ratios. We performed stochastic and probabilistic sensitivity analyses to identify parameter thresholds that affect optimal management, using a willingness-to-pay threshold of $50,000/QALY.
RESULTS: With watchful waiting, 39% ultimately required repair (14% emergent) and 24% recurred. Seventy per cent recurred with repair at diagnosis. Laparoscopic repair at diagnosis was cost-effective compared with open repair at diagnosis (incremental cost-effectiveness ratio $27,700/QALY). The choice of operative strategy (open vs laparoscopic) was sensitive to cost and postoperative quality of life. When perioperative mortality exceeded 5.2% or yearly recurrence exceeded 19.2%, watchful waiting became preferred.
CONCLUSIONS: Ventral hernia repair at diagnosis is very cost-effective. The choice between open and laparoscopic repair depends on surgical costs and postoperative quality of life. In patients with high risk of perioperative mortality or recurrence, watchful waiting is preferred.

Entities:  

Mesh:

Year:  2019        PMID: 29194083     DOI: 10.1097/SLA.0000000000002507

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  What's New in the Management of Incarcerated Hernia.

Authors:  Caroline E Reinke; Brent D Matthews
Journal:  J Gastrointest Surg       Date:  2019-10-21       Impact factor: 3.452

2.  Operative management of non-elective incisional hernia reduces readmission in a national database.

Authors:  J Nigh; D J Wade; G T Rives; S A Karim; A Bhavaraju; M K Kimbrough; R J Reif; K W Sexton; H K Jensen
Journal:  Hernia       Date:  2022-06-28       Impact factor: 4.739

3.  Short-term complications after minimally invasive retromuscular ventral hernia repair: no need for preoperative weight loss or smoking cessation?

Authors:  J R Ekmann; M W Christoffersen; K K Jensen
Journal:  Hernia       Date:  2022-08-22       Impact factor: 2.920

4.  Chances of Mortality Are 3.5-Times Greater in Elderly Patients with Umbilical Hernia Than in Adult Patients: An Analysis of 21,242 Patients.

Authors:  Saral Patel; Abbas Smiley; Cailan Feingold; Bardia Khandehroo; Agon Kajmolli; Rifat Latifi
Journal:  Int J Environ Res Public Health       Date:  2022-08-21       Impact factor: 4.614

5.  Asymptomatic abdominal wall and incisional hernias: Is therapeutic decision consensual? An international survey.

Authors:  Romain Jaquet; Benjamin Darnis; Pierre Emmanuel Bonnot; Kayvan Mohkam; Guillaume Passot
Journal:  Ann Med Surg (Lond)       Date:  2020-10-24

6.  Efficacy Evaluation of a Case-Specific Approach for Surgical Treatment of Inicisional Ventral Hernia.

Authors:  Svetlana Sokolova; Andrey Sherbatykh; Konstantin Tolkachev; Vladimir Beloborodov; Vadim Dulskiy; Natalia Kozlova; Vladimir Vorobev
Journal:  Int J Surg Protoc       Date:  2021-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.